BCG
ABBV icon

BRIA Capital Group’s AbbVie ABBV Stock Holding History

BRIA Capital Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.31M Buy
4,999
+963
+24% +$247K 0.89% 33
2026
Q2 		$1.02M Buy
4,036
+2,975
+280% +$640K 0.75% 33
2026
Q1 		$231K Buy
1,061
+101
+11% +$22.4K 0.21% 60
2025
Q4 		$219K Buy
+960
New +$219K 0.2% 45

Other funds holding ABBV

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

BRIA Capital Group's ABBV Position: Q3 2026 in Review

BRIA Capital Group increased its AbbVie (ABBV) stake by 24% in Q3 2026, buying an estimated $247K and bringing the position to 4,999 shares worth $1.31M. The position accounts for 0.89% of the portfolio, ranked #33.

BRIA Capital Group first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 2,437 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • BRIA Capital Group held 4,999 shares of AbbVie worth $1.31M as of Q3 2026.
  • BRIA Capital Group bought 963 AbbVie shares in Q3 2026, an estimated $247K.
  • AbbVie made up 0.89% of BRIA Capital Group's portfolio in Q3 2026, its #33 holding.
  • BRIA Capital Group first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 2,437 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on BRIA Capital Group's 13F filing for Q3 2026, filed 22 Oct 2026.